analyst
AK
NASDAQ · AKBA
Akebia Therapeutics, Inc.
Healthcare · Biotechnology
$0.91
Up+$0.05 (+5.05%)
Updated Aug 27, 2026, 3:35 PM
SID Score
3.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 347.63M
- P/E ratio
- -65.04
- Dividend yield
- 0.00%
- 52-week range
- $0.81 – $3.22
- Volume
- 14.03M
- Avg. volume
- 3.34M
Price performance
AKBA price history
1M range · 21 trading sessions · Daily adjusted prices
AKBA closed at $0.91 after 21 trading sessions, down 28.06% for the selected period.
- Last close
- $0.91
- Period change
- -28.06%
- Period low
- $0.84
- Period high
- $1.35
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 26, 2026 | $0.957 | $0.957 | $0.8762 | $0.9065 | 14.03M |
| Aug 25, 2026 | $0.90 | $0.963 | $0.90 | $0.9584 | 11.34M |
| Aug 24, 2026 | $0.9078 | $0.9106 | $0.8723 | $0.9006 | 8.13M |
| Aug 21, 2026 | $0.9249 | $0.955 | $0.9055 | $0.9066 | 6.45M |
| Aug 20, 2026 | $0.88 | $0.9298 | $0.8722 | $0.9194 | 13.72M |
| Aug 19, 2026 | $0.8518 | $0.8977 | $0.85 | $0.8854 | 9.88M |
| Aug 18, 2026 | $0.8569 | $0.8626 | $0.8382 | $0.8518 | 1.96M |
| Aug 17, 2026 | $0.87 | $0.88 | $0.814 | $0.86 | 4.26M |
| Aug 14, 2026 | $0.87 | $0.8882 | $0.8581 | $0.8728 | 2.09M |
| Aug 13, 2026 | $0.9046 | $0.949 | $0.8641 | $0.8696 | 4.09M |
| Aug 12, 2026 | $0.8724 | $0.91 | $0.867 | $0.8932 | 4.55M |
| Aug 11, 2026 | $0.84 | $0.8849 | $0.84 | $0.8665 | 3.79M |
| Aug 10, 2026 | $0.90 | $0.909 | $0.8367 | $0.844 | 8.49M |
| Aug 7, 2026 | $0.961 | $0.962 | $0.8862 | $0.9099 | 10.93M |
| Aug 6, 2026 | $0.9021 | $1.01 | $0.85 | $0.9544 | 17.69M |
| Aug 5, 2026 | $1.32 | $1.355 | $1.28 | $1.29 | 4.53M |
| Aug 4, 2026 | $1.31 | $1.35 | $1.31 | $1.32 | 2.7M |
| Aug 3, 2026 | $1.31 | $1.34 | $1.295 | $1.31 | 2.1M |
| Jul 31, 2026 | $1.34 | $1.3491 | $1.295 | $1.32 | 2.06M |
| Jul 30, 2026 | $1.24 | $1.36 | $1.24 | $1.35 | 3.12M |
| Jul 29, 2026 | $1.26 | $1.28 | $1.24 | $1.26 | 1.96M |
Latest AKBA news
The latest Smart Investors Daily articles mentioning AKBA.
Stock researchResearch & News · SEC Filings
Loading stock research…